Sanara MedTech Inc. (SMTI)
NASDAQ: SMTI · Real-Time Price · USD
18.70
-0.23 (-1.22%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Sanara MedTech Revenue
In the year 2025, Sanara MedTech had annual revenue of $103.12M with 18.97% growth. Sanara MedTech had revenue of $27.55M in the quarter ending December 31, 2025, with 4.72% growth.
Revenue (ttm)
$103.12M
Revenue Growth
+18.97%
P/S Ratio
1.66
Revenue / Employee
$954,796
Employees
108
Market Cap
171.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 103.12M | 16.45M | 18.97% |
| Dec 31, 2024 | 86.67M | 21.68M | 33.36% |
| Dec 31, 2023 | 64.99M | 19.15M | 41.77% |
| Dec 31, 2022 | 45.84M | 21.70M | 89.87% |
| Dec 31, 2021 | 24.14M | 8.56M | 54.90% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AngioDynamics | 313.73M |
| OraSure Technologies | 115.02M |
| Pro-Dex | 72.10M |
| KORU Medical Systems | 41.13M |
| Utah Medical Products | 37.53M |
| Stereotaxis | 32.38M |
| Nyxoah | 11.76M |
| Anteris Technologies Global | 1.91M |
SMTI News
- 15 days ago - Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026 - GlobeNewsWire
- 15 days ago - Sanara MedTech, Inc. Investigated by the Portnoy Law Firm - GlobeNewsWire
- 5 weeks ago - Sanara MedTech Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance - GlobeNewsWire
- 7 weeks ago - Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds - GlobeNewsWire
- 2 months ago - Sanara MedTech Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 - GlobeNewsWire
- 2 months ago - Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rd - GlobeNewsWire